*From the Department of Pediatrics

†Department of Infectious Diseases, Infection Control, and Employee Health

‡Department of Biostatistics, The University of Texas MD Anderson Cancer Center

§Pharmacy Practice and Translational Research, The University of Houston College of Pharmacy, Houston, Texas.

Accepted for publication October 13, 2023

P.O. reports funding from Napo pharmaceuticals, Merck Sharp and Dohme, Melinta pharmaceuticals and Summit pharmaceuticals. The other authors have no conflicts of interest to disclose.

Address for correspondence: Brianna Murphy, DO, Department of Pediatrics, Sanford Children’s Specialty Clinic, 1600 W 22nd Street, Sioux Falls, SD, 57117. E-mail: [email protected] or Natalie J. Dailey Garnes, MD MPH MS, MD Anderson Cancer Center, Department of Infectious Disease, 1515 Holcombe blvd Unit 1460, Houston, TX, 77030. E-mail: [email protected].